258 related articles for article (PubMed ID: 37790926)
1. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
2. TLR4, but Neither Dectin-1 nor Dectin-2, Participates in the Mollusk Hemocyanin-Induced Proinflammatory Effects in Antigen-Presenting Cells From Mammals.
Jiménez JM; Salazar ML; Arancibia S; Villar J; Salazar F; Brown GD; Lavelle EC; Martínez-Pomares L; Ortiz-Quintero J; Lavandero S; Manubens A; Becker MI
Front Immunol; 2019; 10():1136. PubMed ID: 31214162
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
4. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
6. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.
Planès R; Ben Haij N; Leghmari K; Serrero M; BenMohamed L; Bahraoui E
J Virol; 2016 Jul; 90(13):5886-5898. PubMed ID: 27053552
[TBL] [Abstract][Full Text] [Related]
8. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of TRIF bias and adjuvanticity.
Richard K; Perkins DJ; Harberts EM; Song Y; Gopalakrishnan A; Shirey KA; Lai W; Vlk A; Mahurkar A; Nallar S; Hawkins LD; Ernst RK; Vogel SN
Vaccine; 2020 Jun; 38(27):4298-4308. PubMed ID: 32389496
[TBL] [Abstract][Full Text] [Related]
10. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.
Gandhapudi SK; Chilton PM; Mitchell TC
PLoS One; 2013; 8(2):e56855. PubMed ID: 23457630
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
12. Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation.
Cheng Z; Taylor B; Ourthiague DR; Hoffmann A
Sci Signal; 2015 Jul; 8(385):ra69. PubMed ID: 26175492
[TBL] [Abstract][Full Text] [Related]
13. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
Buchholz BM; Billiar TR; Bauer AJ
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
[TBL] [Abstract][Full Text] [Related]
14. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
16. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
17. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
[TBL] [Abstract][Full Text] [Related]
18. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.
George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S
Front Immunol; 2022; 13():961094. PubMed ID: 36119026
[No Abstract] [Full Text] [Related]
19. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
